These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 13571124)

  • 1. Evaluation of antihypertensive effects of S. 9-390 (2-(o-chlorobenzyl) imidazoline hydrochloride.
    ROCHELLE D; FORD RV
    Am Heart J; 1958 Sep; 56(3):463-8. PubMed ID: 13571124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical results of oral and parenteral administration of 2-(N'p-tolyl-N'-m-hydroxyphenylaminomethyl) imidazoline hydrochloride (regitine) in the treatment of hypertension and an evaluation of the cerebral hemodynamic effects.
    MOYER JH; CAPLOVITZ C
    Am Heart J; 1953 Apr; 45(4):602-10. PubMed ID: 13030411
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic changes following adminstration of dichlorophenylamino-imidazoline hydrochloride in acute and chronic experiments].
    Schneider KW; Gattenlöhner W; Müller W
    Verh Dtsch Ges Inn Med; 1967; 73():611-6. PubMed ID: 4873599
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
    Caparello O; Contino A; Viola A; Pirro G
    Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Curri G
    Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical observations on a new antihypertensive drug, 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride.
    Smet G; Hoobler SW; Sanbar S; Julis S
    Am Heart J; 1969 Apr; 77(4):473-8. PubMed ID: 5773738
    [No Abstract]   [Full Text] [Related]  

  • 8. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
    Langer-Costanzi M
    Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
    [No Abstract]   [Full Text] [Related]  

  • 10. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
    Brunner H; Djawan S; Dorda W; Penner E; Grabner G
    Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of benzazoline (2-benzyl-4,5-imidazoline hydrochloride) (priscoline) on renal function in hypertensive man.
    ULLMANN TD; STEIN JA
    Angiology; 1955 Feb; 6(1):37-46. PubMed ID: 14350294
    [No Abstract]   [Full Text] [Related]  

  • 12. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Benzyl-imidazoline hydrochloride in hemiplegia.
    ANNAMALAI AL
    J Indian Med Assoc; 1956 Jul; 27(1):5-6. PubMed ID: 13346106
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the therapy of hypertension with an imidazoline derivative].
    Krause W; Krämer D; Grünitz B
    Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical assessment of prolonged therapy of patients with hypertension and diabetes with imidazoline receptor agonist moxonidine].
    Trusov VV; Aksenov KV; Filimonov MA
    Kardiologiia; 2002; 42(2):50-3. PubMed ID: 12494208
    [No Abstract]   [Full Text] [Related]  

  • 17. Acrodynia treated with 2-benzyl-imidazoline hydrochloride.
    GILLESPIE AE
    Can Med Assoc J; 1952 Nov; 67(5):418-21. PubMed ID: 13009581
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hydrolysis of 2-phenyl-benzylaminomethyl-imidazoline hydrochloride].
    BUCZKOWSKI Z
    Acta Pol Pharm; 1955; 11(Suppl):31-2. PubMed ID: 13248625
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of priscol (2-benzyl-4,5-imidazoline hydrochloride) in the treatment of peripheral vascular diseases.
    FRANK N; STRAZZA JA; HELSPER JT
    Ann Intern Med; 1951 Jul; 35(1):19-38. PubMed ID: 14847446
    [No Abstract]   [Full Text] [Related]  

  • 20. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.